Sekisui House, Ltd.: Working With Customers for 20 Years to Conserve Urban Biodiversity With the Gohon no ki Indigenous Landscaping Concept
Sekisui House, Ltd. (TOKYO:1928) has been pursuing the conservation of biodiversity since 2001 by creating green networks in urban residential districts under its Gohon no ki (“five trees”) indigenous landscaping concept. Together with the University of the Ryukyus1, the company has analyzed the outcome of the Gohon no ki Project that it has implemented with 1 million customer households2 over the space of 20 years, and has designed the world’s first mechanism for quantitatively evaluating urban biodiversity. It has published this qualitative evaluation mechanism today as a nature-positive methodology for promoting the conservation of biodiversity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130005350/en/
Results of quantitative evaluation analysis (1) - The number of native tree species in each region—the foundation of regional biodiversity—has increased tenfold. (Graphic: Business Wire)
The Gohon no ki Project
Since the 1970s, incessant urban development has dramatically reduced the amount of habitat available for flora and fauna in our cities. Sekisui House launched its Gohon no ki Project in 2001 as an initiative to conserve biodiversity through the eco-friendly landscaping and greening of the gardens of its customers. Based on the concept of planting five locally native trees, three for birds and two for butterflies, the Gohon no ki Project proposes greening gardens and local communities with native tree species suited to the local climate and benevolent to birds, butterflies, and other local fauna. The project takes its lead from garden landscaping modeled on traditional Japanese satoyama (which translates roughly as “village woodland”).
In the 20 years from 2001 up to 2020, more than 17 million trees have been planted under the project. The company has also promoted urban greening throughout Japan by incorporating the Gohon no ki concept into its planning of green spaces in its condominium and community development initiatives.
Quantitative evaluation of biodiversity
Sekisui House has since 2019 been working with the Kubota Laboratory, Faculty of Science, University of the Ryukyus, and Think Nature Inc. to quantitatively evaluate the contribution of this network-type greening to urban biodiversity. Based on the Japan Biodiversity Mapping Project (J-BMP)3 managed and operated by Think Nature Inc., a company established by Professor Yasuhiro Kubota, the partners have analyzed the data on tree number, species, and location accumulated over the 20 years of the Sekisui House Gohon no ki Project to quantitatively evaluate the effectiveness of the project in conserving and restoring biodiversity.
This quantitative evaluation revealed the following benefits for biodiversity from planting native tree species in line with the Gohon no ki Project as opposed to planting conventional horticultural and exotic species in gardens in urban areas where biodiversity has declined significantly (Japan’s three major metropolitan areas).4
- The number of native tree species in each region—the foundation of regional biodiversity—has increased tenfold.
- The number of bird species that residential districts can attract has doubled.
- The number of butterfly species that residential districts can attract has increased fivefold.
- Biodiversity in the three metropolitan areas has recovered to 30% of the level of 1977 for which the first trustworthy biodiversity related data exists.
This is the world’s first mechanism for quantitatively evaluating urban biodiversity and its application to an actual case. The disclosure of numerical data enables biodiversity to be expressed in terms of financial value, thereby providing a means for visualizing private sector contribution to biodiversity.
In recent years, increasing efforts are being made to conserve biodiversity. In June of this year, the Taskforce on Nature-related Financial Disclosures (TNFD) was launched, and in October, the 15th Conference of the Parties to the Convention on Biological Diversity (COP15) was held. In Japan too, discussion has begun in earnest on other effective area-based conservation measures (OECMs) for enlisting the support of the private sector to drive urban greening.
In this societal context, Sekisui House is making its 20-year biodiversity conservation initiative available to the public as a nature-positive methodology. The Gohon no ki Project’s nature-positive methodology represents a means for expressing urban biodiversity. Sekisui House is making this methodology available to the general public with the aim of raising awareness and enabling its store of knowledge and expertise to be utilized by others to promote greening and contribute to the conservation of biodiversity.
Nature-positive methodology website
Based on joint review of available data, Sekisui House and its partners set the number of tree, bird, and butterfly species, diversity index, and number of individual trees, birds, and butterflies in 1977 as 100%, and using 2000, the year before the Gohon no ki Project was launched, as the base year, simulated change up to 2070 in Japan’s three largest metropolitan areas (Kanto, Kinki and Chukyo) that have suffered the greatest decline in biodiversity. This simulation indicated that planting native tree species that are likely to benefit local fauna (the Gohon no ki concept) compared to 2000, the year before the launch of the Gohon no ki Project, would enable biodiversity to recover to 37.4% of 1977 levels by 2030 (target year for conservation of biodiversity internationally), 40.9% by 2050, and 41.9% by 2070.
If the Gohon no ki concept of planting native trees were applied to 30% of all newly constructed properties in Japan moving forward, urban biodiversity is predicted to rise to 84.6% of 1977 levels. Sekisui House believes that this indicates that if the private sector works with the general public, the decline in biodiversity can be reversed to achieve the goal of post-2020 biodiversity recovery that is the theme of COP15, and that its Gohon no ki concept can contribute to this goal.
We've received comments of endorsement from the following people. For more details, please refer to the attached document or the original news release via your browser.
- Mr. Makoto Haraguchi, Fellow, MS & AD InterRisk Research Institute and Sustainability Section SVP for TNFD, MS & AD Insurance Group Holdings
- Mr. Teppei Dohke, Executive Secretary General of the Japan Committee for the International Union for Conservation of Nature
- Ms. Mariko Kawaguchi, Specially Appointed Professor, Rikkyo University / Executive Advisor to CEO, Fuji Oil Holdings Inc.
- Mr. Yasuhiro Kubota, Professor, Faculty of Science, University of the Ryukyus / Representative Director, Think Nature Inc.
1. This is joint research with the Kubota Laboratory, Faculty of Science, University of the Ryukyus.
2. Cumulative number of households built from February 2001 to January 2021 is 1,001,977.
3. Japan Biodiversity Mapping Project (J-BMP) website: https://biodiversity-map.thinknature-japan.com
4. Comparison of continuing to plant conventional garden tree species with planting tree species in line with the Gohon no ki concept over the 20 years from 2001 to 2020
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Sekisui House, Ltd. Public Relations Office (in actio inc.)
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Specifica Validates Best-in-Class Status for in vitro Antibody Discovery Platform in Two Key Peer Reviewed Publications29.1.2022 02:00:00 EET | Press release
Specifica, a privately held antibody engineering company focused on innovative in vitro antibody library and discovery tools, announced the publication of two peer-reviewed articles describing its Generation 3 Antibody Discovery Platform1,2. Antibodies are the fastest growing class of therapeutics, representing nine of the top twenty best-selling drugs3. The global antibody therapy market is projected to grow from $178.50 billion in 2021 to $451.89 billion in 2028 at a CAGR of 14.1%4. Traditionally, therapeutic antibodies have been generated by harvesting immune responses, either from in-bred or transgenic mice, or from immune human subjects. Although there has been a long-standing interest in using in vitro antibody library approaches that avoid the use of animals, there have been two main concerns with antibodies from in vitro libraries: binding affinities tend to be lower, and poor developability characteristics are common, complicating their development as successful drugs. As desc
ADVA Optical Networking SE: Acorn HoldCo, Inc. reaches minimum acceptance threshold for its public exchange offer to all shareholders of ADVA Optical Networking SE29.1.2022 01:45:00 EET | Press release
ADTRAN, Inc. today announced that by the end of the acceptance period on January 26, 2022, 24:00 hours (local time Frankfurt am Main), the voluntary public takeover offer of Acorn HoldCo, Inc. (“Bidder”) to all shareholders of ADVA Optical Networking SE (“ADVA“) has been accepted for more than 60% of all ADVA shares entitled to voting rights and existing as of October 31, 2021. The minimum acceptance threshold has therefore been reached. The final result as at the end of the acceptance period is expected to be published on January 31, 2022. ADTRAN, Inc. and ADVA have thus reached yet another important milestone for the merger of the two companies and have come closer to their goal of creating a leading company in the field of optical transmission technology for enterprise, access and wide-area networks. The consummation of the public exchange offer continues to be subject to closing conditions not yet fulfilled, especially foreign direct investment approval in Germany. ADVA shareholder
causaLens Raises $45m Series A to Scale Human-centered AI That Understands Cause-and-effect28.1.2022 17:46:00 EET | Press release
causaLens, the London deep tech company delivering the future of AI, has raised a $45m Series A round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220126005888/en/ The causaLens co-founders, Dr. Maksim Sipos, CTO, on the left, and Dr. Darko Matovski, CEO, on the right. (Photo: Business Wire) causaLens is the pioneer of Causal AI - the only AI technology quantifying cause-and-effect relationships to reason alongside humans in a manner that is trustworthy, explainable, and fair. Causal AI represents a giant leap ahead of current correlation-based AI technologies, which blindly extrapolate historical data and are unable to ask counterfactual questions — the ‘what ifs’ at the core of human imagination and creativity. causaLens’s no-code platform delivers far more accurate and reliable results, and allows humans and machines to work together for the first time. It is trusted by decision makers across finance, industry, technol
Monrol Signing Agreement to License its GMP Grade Lu-177 n.c.a Production Technology to Curium28.1.2022 15:47:00 EET | Press release
Eczacıbaşı-Monrol Nuclear Products Co. (Monrol) has today announced it has signed an agreement with Curium Netherlands B.V (Curium) to license its GMP grade medical radioisotope, no-carrier-added 177Lu (n.c.a. 177Lu) cutting-edge production technology LuMagic®. This agreement will enable transfer of relevant equipment and supply from Monrol to Curium. Monrol is one of the few producers of Lutetium-177 n.c.a worldwide, having uninterrupted worldwide supply capabilities. Monrol Lu-177 n.c.a production process is an exclusive processing technology having cleaner and safer production method with stable isotope enrichment capability. Curium planning to manufacture the product Lu-177 n.c.a in its Petten production facility, Netherlands. This licence is offering significant opportunities both for Curium; one of the world’s largest nuclear medicine companies and Monrol; a company which develops, manufactures, and distributes world-class radiopharmaceutical products, radioisotopes to improve qu
CHMP issues positive opinion to expand Jardiance (empagliflozin) indication based on unprecedented benefit in adult heart failure patients with preserved ejection fraction28.1.2022 15:26:00 EET | Press release
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending Jardiance® (empagliflozin) for the treatment of adults with symptomatic chronic heart failure, Boehringer Ingelheim and Eli Lilly and Company announced today.1 Empagliflozin was previously approved for the treatment of adults with symptomatic chronic heart failure with reduced ejection fraction (HFrEF).4 If approved, the positive opinion would expand this indication to be applicable for adults across the full spectrum of left ventricular ejection fraction (LVEF), including preserved ejection fraction (HFpEF). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220127005861/en/ “For the very first time, we now have a treatment that will improve clinical results across the full spectrum of heart failure patients – regardless of ejection fraction,” said Professor Stefan Anker, Heart Failure Car
Schlumberger DELFI Digital Platform Selected by Northern Lights JV for CO2 Project28.1.2022 15:00:00 EET | Press release
Schlumberger will deploy the DELFI* cognitive E&P environment on the Norwegian CO2 project by the Northern Lights Joint Venture (NL), to streamline subsurface workflows and longer-term modeling and surveillance of CO2 sequestration. NL was established to develop the world’s first open-source CO2 transport and storage infrastructure, providing accelerated decarbonization opportunities for European industries, with an ambition to store up to 5 million tonnes of CO2 per year based on market demand. For CO2 transportation and storage, Schlumberger digital solutions are used for subsurface characterization and dynamic reservoir simulation, which are key to understanding storage site capacity and the potential for injecting and containing fluids. They are also used for development planning, operations, appraisals, and monitoring purposes. “Northern Lights has recognized the huge potential of Schlumberger’s digital technology to fast-track decision making and de-risk CO2 transportation and st
Pixis Appoints Neel Pandya as the CEO for Europe Business, in Addition to APAC28.1.2022 14:28:00 EET | Press release
Pixis (formerly known as Pyxis One), a leading provider of contextual codeless AI infrastructure for complete marketing optimization, today appointed Neel Pandya as the Chief Executive Officer of its operations in Europe, in addition to his responsibilities of leading the APAC business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220128005166/en/ Neel Pandya joined Pixis as the CEO of APAC in its Bengaluru office after exiting L'Oréal. (Photo: Business Wire) Neel joined Pixis in its Bengaluru office in July 2021 as the CEO of APAC, bringing immense change and progress to the way Pixis operates, and greatly streamlining expansions in the APAC region. Under his leadership, Pixis witnessed a 185% growth in revenue in the APAC region, with India independently recording a 150% of growth. Over the last 7 months, in addition to greatly stabilizing customer churn Neel has also been instrumental in adding close to 30 new enterpris
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom